Cartesian Therapeutics (RNAC) Shares Issued (2015 - 2026)

Cartesian Therapeutics (RNAC) has 12 years of Shares Issued data on file, last reported at $15.4 million in Q1 2026.

• Shares Issued for Q1 2026 came in at $15.4 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $15.4 million (changed N/A YoY), and the FY2024 annual result was $2.9 million, changed N/A from the prior year.
• Shares Issued climbed to $15.4 million in Q1 2026 per RNAC's latest filing, from -$273000.0 in the prior quarter.
• Over five years, Shares Issued peaked at $9.4 billion in Q2 2022 and troughed at -$121.6 million in Q4 2024.
• A 5-year average of $1.5 billion and a median of $273000.0 in 2025 frame the typical range for Shares Issued.
• The sharpest annual moves came in 2022 and 2024: Shares Issued soared 10585356.18% in 2022, then slumped 52523.81% in 2024.
• A 5-year view of Shares Issued shows it stood at $36.7 million in 2022, then slumped by 100.63% to -$231000.0 in 2023, then tumbled by 52523.81% to -$121.6 million in 2024, then surged by 99.78% to -$273000.0 in 2025, then jumped by 5738.1% to $15.4 million in 2026.
• Business Quant data shows RNAC's Shares Issued at $15.4 million in Q1 2026, -$273000.0 in Q4 2025, and $273000.0 in Q3 2025.